Healthcare Technology Poised to Transform Medical Diagnostics and Treatment General Motors Unveils AllElectric Cadillac Vistiq with 300Mile Range OpenAI Moves to the Forefront of the AI IPO Race Getting to Public Markets First Is Very Important USChina Trade Talks Show Persistent Divergence at APEC Berkshire Hathaway Returns to Skies with 26 Billion Delta Air Lines Stake Caseys General Stores CASY Gains Attention After Jim Cramers Hidden Gem Endorsement QDEL Q1 2026 Earnings Severe EPS Miss Amidst Revenue Uncertainty BTE Q1 2026 Earnings Significant Earnings Miss Highlights Operational Headwinds PKX Q4 2025 Earnings Massive EPS Miss Highlights Severe Operational Headwinds BWFG Q1 2026 Earnings EPS Surpasses Estimates by 13 on Strong Operational Performance ASND Q1 2026 Earnings EPS Misses Estimates as Loss Widens Shares Edge Lower Edgewell Personal Care Company EPC Q1 2026 Earnings EPS Misses Estimates Amid Cost Pressures Yuanbao Inc YB Surges Over 5 as Bullish Momentum Builds Above Key Support Yorkville Acquisition Corp Unit MCGAU Holds Steady at 1029 A Static SPAC Unit Under Scrutiny Halozyme Therapeutics HALO Edges Higher as Stock Holds Above Key Support Level U Power Limited UCAR Faces Continued Pressure as Shares Slide Nearly 4 TJX Companies Edges Higher Amid Modest Gains Key Levels in Focus World Insurance Expands Midwest Footprint with Kansas Agency Acquisition Omnicom Q1 2026 Earnings EPS Beats Estimates as Agency Demand Remains Resilient Grupo Televisa TV Edges Lower as Media Stock Tests Support Near 268 HTZ Q1 2026 Earnings NarrowerThanExpected Loss Boosts Sentiment KORE Q1 2026 Earnings Earnings Miss Estimates by Wide Margin Stock Reacts Modestly Energy Focus EFOI Q4 2024 Earnings Narrower Loss Amid Operational Adjustments Shares Edge Higher RDHL Q2 2022 Earnings Deep Losses and Share Price Surge Amid No Revenue WRB Q1 2026 Earnings Strong Underwriting and Investment Performance Drive 124 EPS Beat ACRE Q1 2026 Earnings Disappointing EPS Miss Amidst Challenging Commercial Real Estate Market Jade Biosciences Inc JBIO Q1 2026 Earnings Clinicalstage Biotech Misses Consensus as Cash Burn Accelerates